{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T22:36:51Z","timestamp":1718577411326},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T00:00:00Z","timestamp":1344470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s11096-012-9685-4","type":"journal-article","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T07:09:37Z","timestamp":1344409777000},"page":"822-824","source":"Crossref","is-referenced-by-count":9,"title":["Tardive dyskinesia after short-term treatment with oral metoclopramide in an adolescent"],"prefix":"10.1007","volume":"34","author":[{"given":"Maryam","family":"Karimi Khaledi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie J.","family":"Suda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chasity M.","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,9]]},"reference":[{"key":"9685_CR1","unstructured":"Food and Drug Administration. FDA Requires Boxed Warning and Risk Mitigation Strategy for Metoclopramide-Containing Drugs [internet] (2009) [cited 2012 Jan 29]. Available from: http:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm149533.htm ."},{"key":"9685_CR2","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1176\/ajp.151.6.836","volume":"151","author":"G Gardos","year":"1994","unstructured":"Gardos G, Casey DE, Cole JO, Pereny A, Kocsis E, Arato M, et al. Ten year outcome of tardive dyskinesia. Am J Psychiatry. 1994;151:836\u201341.","journal-title":"Am J Psychiatry"},{"key":"9685_CR3","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1176\/ajp.155.11.1521","volume":"155","author":"MG Woerner","year":"1998","unstructured":"Woerner MG, Alvir JM, Saltz BL, Lieberman JA, Kane JM. Prospective study of tardive dyskinesia in the elderly: rates and risk factors. Am J Psychiatry. 1998;155:1521\u20138.","journal-title":"Am J Psychiatry"},{"key":"9685_CR4","first-page":"23","volume":"126","author":"JD Grimes","year":"1982","unstructured":"Grimes JD, Hassan MN, Preston DN. Adverse neurologic effects of metoclopramide. Can Med Assoc J. 1982;126:23\u20135.","journal-title":"Can Med Assoc J"},{"key":"9685_CR5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/oxfordjournals.schbul.a006926","volume":"28","author":"SR Marder","year":"2002","unstructured":"Marder SR, Essock SM, Miller AL, Buchanan RW, Davis JM, Kane JM, et al. The Mount Sinai conference on the pharmacotherapy of schizophrenia. Schizophr Bull. 2002;28:5\u201316.","journal-title":"Schizophr Bull"},{"key":"9685_CR6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1176\/appi.ajp.159.2.180","volume":"159","author":"S Leucht","year":"2002","unstructured":"Leucht S, Pitschel-Walz G, Engel RR, Kissling W. Amisulpride, an unusual \u201catypical\u201d antipsychotic: a meta-analysis of randomized controlled trials. Am J Psychiatry. 2002;159:180\u201390.","journal-title":"Am J Psychiatry"},{"key":"9685_CR7","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/archinte.1989.00390110070015","volume":"149","author":"LG Miller","year":"1989","unstructured":"Miller LG, Jankovic J. Metoclopramide-induced movement disorders. Clinical findings with a review of literature. Arch Inter Med. 1989;149:2486\u201392.","journal-title":"Arch Inter Med"},{"key":"9685_CR8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2036.2009.04189.x","volume":"31","author":"AS Rao","year":"2010","unstructured":"Rao AS, Camilleri M. Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther. 2010;31:11\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"9685_CR9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345.","journal-title":"Clin Pharmacol Ther"},{"key":"9685_CR10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/mds.20259","volume":"20","author":"NI Mejia","year":"2005","unstructured":"Mejia NI, Jankovic J. Metoclopramide-induced tardive dyskinesia in an infant. Mov Disord. 2005;20:86\u20139.","journal-title":"Mov Disord"},{"key":"9685_CR11","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0022-3476(05)80357-9","volume":"121","author":"PE Putnam","year":"1992","unstructured":"Putnam PE, Orenstien SR, Wessel HB, Stowe RM. Tardive dyskinesia associated with the use of metoclopramide in a child. J Pediatr. 1992;121:983\u20135.","journal-title":"J Pediatr"},{"key":"9685_CR12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/0091270007312258","volume":"48","author":"C Kenney","year":"2008","unstructured":"Kenney C, Hunter C, Davidson A, Jankovic J. Metoclopramide, an increasingly recognized cause of tardive dyskinesia. J Clin Pharmacol. 2008;48:379\u201384.","journal-title":"J Clin Pharmacol"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-012-9685-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-012-9685-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-012-9685-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T05:54:38Z","timestamp":1559368478000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-012-9685-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,9]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["9685"],"URL":"https:\/\/doi.org\/10.1007\/s11096-012-9685-4","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,9]]}}}